NASDAQ$GNTLF

Genetic Technologies Ltd · Q1 2025 earnings

Q1 2025 earnings · · Investor relations

Reports awaiting report

Genetic Technologies hasn't published Q1 2025 actuals yet. The tiles below frame what to compare against; sections further down are historical context only.

  • Most recent report

    Q2 2024

    Revenue
    $2.7M
    EPS
    -$1.09
  • FY2025 consensus

    Analyst consensus

    Revenue
    $11.7M
    EPS
    $0.00

Revenue & EPS history

Genetic Technologies · Revenue · Quarterly

$2.7M

Q2 2024-5.1%vs Q2 2023
Beat estimate in 1 of 2 quarters(50%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q1 2025

Historical avgQ1 2025

+3.6%

Avg return

Earnings day

-1.0%

Avg return

5 days after

+286.8%

Avg return

30 days after

68%

23 / 34 earnings

Positive

+23.3%

Q2 2021

Best reaction

-8.6%

Q2 2016

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2025+0.0%+0.0%+0.0%
Q2 2024+7.5%+0.0%+0.0%
Q4 2023+7.2%+0.0%+0.0%
Q2 2023+1.1%+0.0%+0.0%
Q4 2022-2.1%+0.0%+420.0%
Q3 2022-2.5%+0.0%+0.0%
Q2 2022+8.0%+0.0%+0.0%
Q1 2022+0.9%+0.0%-75.0%
Q4 2021+0.7%+0.0%+66.7%
Q3 2021+5.8%+0.0%+503.7%
Q2 2021+23.3%+0.0%+4900.0%
Q4 2020-6.8%+0.0%+0.0%
Q2 2020+2.4%+0.0%+0.0%
Q4 2019+4.0%-20.0%-80.0%
Q2 2019+12.5%+0.0%+0.0%
Q4 2018-3.0%+0.0%+0.0%
Q2 2018+5.2%+0.0%+0.0%
Q4 2017+0.0%+0.0%+0.0%
Q2 2017+5.6%+0.0%+0.0%
Q4 2016+7.3%+0.0%+0.0%
Q2 2016-8.6%
Q4 2015+1.9%
Q2 2015+4.2%
Q4 2014-0.9%
Q2 2014-2.0%
Q4 2013+5.8%
Q3 2013+4.4%
Q2 2013+9.3%
Q4 2012-0.3%
Q3 2012+0.3%
Q2 2012+1.3%
Q4 2011+17.2%
Q2 2010+12.0%
Q4 2010+0.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro